Concepedia

Factor Xiii Replacement

Factor XIII Replacement is a therapeutic intervention involving the administration of exogenous factor XIII to correct congenital or acquired factor XIII deficiency, thereby restoring the blood's ability to form stable fibrin clots.

159

Publications

7.4K

Citations

900

Authors

381

Institutions

Publications per year

2017–2026

14

Parents

Publications

159

Efficacy and Safety of Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage

Stephan A. Mayer, Nikolai C. Brun, Kamilla Begtrup et al. · New England Journal of Medicine · 2008 · 1.3K citations · Full text

, , +16

Guidelines for the use of recombinant activated factor VII (rFVIIa) in uncontrolled bleeding: a report by the Israeli Multidisciplinary rFVIIa Task Force

U. Martinowitz, Moshe Michaelson · Journal of Thrombosis and Haemostasis · 2005 · 301 citations · Full text

, , +12

Prophylactic and therapeutic recombinant factor VIIa administration to patients with Glanzmann's thrombasthenia: results of an international survey

M‐C. Poon, Roseline d’Oiron, Mario von Depka et al. · Journal of Thrombosis and Haemostasis · 2004 · 197 citations · Full text

, , +13

Recombinant Factor VIIa Is Effective for Bleeding and Surgery in Patients With Glanzmann Thrombasthenia

Man‐Chiu Poon, Christine Demers, F Jobin et al. · Blood · 1999 · 196 citations

, , +12

Production of human factor IX in animals by genetically modified skin fibroblasts: potential therapy for hemophilia B

TD Palmer, AR Thompson, A. Dusty Miller · Blood · 1989 · 177 citations · Full text

, , +13

1–5 of 159

Authors

900

  1. KK
    Keyvan Karkouti

    University of Toronto, Canada

    4 publications · 174 citations

    4

    h-index

  2. AD
    Amy D. Shapiro

    Indiana Hemophilia and Thrombosis Center, United States

    4 publications · 151 citations

    4

    h-index

  3. MG
    Muriel Giansily‐Blaizot

    Centre Hospitalier Universitaire de Montpellier, France

    3 publications · 90 citations

    3

    h-index

  4. JS
    Jean‐François Schved

    Centre Hospitalier Universitaire de Montpellier, France

    3 publications · 137 citations

    3

    h-index

  5. JM
    Johnny Mahlangu

    University of the Witwatersrand, South Africa

    3 publications · 86 citations

    3

    h-index

1–5 of 900

Institutions

381

  1. Novo Nordisk (Denmark)

    Copenhagen, Denmark

    6 h-index

    10 publications

    3.2K citations

  2. University of Toronto

    Toronto, Canada

    5 h-index

    14 publications

    598 citations

  3. Tel Aviv University

    Tel Aviv, Israel

    4 h-index

    7 publications

    484 citations

  4. Aarhus University Hospital

    Aarhus, Denmark

    4 h-index

    7 publications

    139 citations

  5. Harvard University

    Cambridge, United States

    4 h-index

    22 publications

    3K citations

  6. Sheba Medical Center

    Ramat Gan, Israel

    4 h-index

    11 publications

    524 citations

  7. Federico II University Hospital

    Naples, Italy

    4 h-index

    13 publications

    594 citations

  8. Royal Prince Alfred Hospital

    Sydney, Australia

    4 h-index

    11 publications

    320 citations

1–8 of 381

Venues

  1. PubMed

    Repository · 12 publications · 210 citations

    11

    h-index

  2. Haemophilia

    12 publications · 294 citations

    11

    h-index

  3. Thrombosis and Haemostasis

    10 publications · 344 citations

    10

    h-index

  4. Journal of Thrombosis and Haemostasis

    JTH · 11 publications · 926 citations

    10

    h-index

  5. Thrombosis Research

    9 publications · 252 citations

    9

    h-index

1–5